InMed is a bio-pharmaceutical company that specializes in the research, development and commercialization of cannabinoid based pharmaceutical products. We take this class of compounds known as cannabinoids and we formulate these into disease specific products to treat diseases with high unmet medical needs.
Article: InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
In this article, read about the prevalence of age-related macular degeneration and InMed’s promising preclinical studies of INM-089, a small molecule drug candidate in development